| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/24/2013 | CN103059105A Method for extraction of colistin sulphate |
| 04/24/2013 | CN103059104A Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 04/24/2013 | CN103059103A Specific CD4+T cell epitope peptide of Hantaan virus nucleoprotein |
| 04/24/2013 | CN103059102A Polypeptide for inhibiting hepatitis C viruses (HCVs) from infecting cells, and its application |
| 04/24/2013 | CN103059101A Antigenic mimic epitope of aflatoxin (AF) B1 and application thereof |
| 04/24/2013 | CN103059100A New peptides useful as dual caspase-2/-6 inhibitor and biological application thereof |
| 04/24/2013 | CN102127146B Method for preparing atosiban acetate |
| 04/24/2013 | CN101974073B Anti-inflammatory hexapeptide |
| 04/24/2013 | CN101880317B Application of determination of anti-M3 receptor altered peptide antibody in diagnosis of sjogren syndrome |
| 04/24/2013 | CN101798337B Mutant of endotoxin neutralizing peptide and application thereof |
| 04/24/2013 | CN101597321B LHRH antagonist with long-acting low-histamine release side effect |
| 04/24/2013 | CN101531703B Beta lamellar blocking peptide for preventing and/or curing Alzheimer's disease |
| 04/24/2013 | CN101511861B Anti-inflammatory and antiallergic cyclic peptides |
| 04/24/2013 | CN101232896B Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 04/23/2013 | US8426560 Microwave-assisted peptide synthesis |
| 04/23/2013 | US8426559 Injectable β-hairpin peptide hydrogel that kills methicillin-resistant Staphylococcus aureus |
| 04/23/2013 | US8426557 IGF-1R binding polypeptides and their use |
| 04/23/2013 | US8426364 Method of preventing progression of hypertension-induced heart failure with PKC peptides |
| 04/23/2013 | US8426359 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/23/2013 | CA2530667C Protein crystal comprising the processivity clamp factor of dna polymerase and a ligand, and its uses |
| 04/23/2013 | CA2493081C Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 04/18/2013 | WO2013056054A2 Peptide inhibitors of bace1 |
| 04/18/2013 | WO2013056008A1 Zymogen activators |
| 04/18/2013 | WO2013055404A1 Meditopes and meditope-binding antibodies and uses thereof |
| 04/18/2013 | WO2013055051A1 Peptide nanostructure and a production method therefor |
| 04/18/2013 | WO2013054329A1 Toll-like receptor 4 (tlr-4) agonist peptides for modulating tlr-4 mediated immune response |
| 04/18/2013 | WO2013053772A1 Antimicrobial peptides for treatment of infectious diseases |
| 04/18/2013 | WO2013053359A1 Diagnostic and prognostic use of prombp-complexes |
| 04/18/2013 | US20130096073 Casein Derived Peptides And Uses Thereof |
| 04/18/2013 | US20130096071 Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders |
| 04/18/2013 | US20130096070 Peptide targeting of inner ear cells |
| 04/18/2013 | US20130096069 Compositions and methods for enhancing drug delivery across and into ocular tissues |
| 04/18/2013 | US20130095139 Bone morphogenic protein binding peptide |
| 04/18/2013 | US20130095128 Ect2 peptides and vaccines including the same |
| 04/18/2013 | US20130095123 New binder-drug conjugates (ADCs) and use thereof |
| 04/18/2013 | US20130095122 Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein |
| 04/18/2013 | US20130095110 Hyaluronic Acid Decomposition-Promoting Factor and Inhibitor Thereof |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | CA2852099A1 Meditopes and meditope-binding antibodies and uses thereof |
| 04/18/2013 | CA2851371A1 Zymogen activators |
| 04/18/2013 | CA2850514A1 Peptide inhibitors of bace1 |
| 04/17/2013 | EP2581383A1 Skin or hair binding peptides |
| 04/17/2013 | EP2580231A1 Peptides, constructs and uses therefor |
| 04/17/2013 | EP2579887A1 Novel auristatin derivatives and use thereof |
| 04/17/2013 | CN1966516B Nanometre collagen oligopeptide and its producing method |
| 04/17/2013 | CN103052647A Anti-viral agent |
| 04/17/2013 | CN103048395A Deletion peptide of 20 peptide phase for solid-phase synthesis of thymosin alpha 1, non-peptide impurity and detection method |
| 04/17/2013 | CN103044529A Method for extracting B1 single component in polymyxin B sulfate |
| 04/17/2013 | CN103044528A Strawberry vein banding virus antibody, and antigen polypeptide, immunogen and application thereof |
| 04/17/2013 | CN103044527A Antigenic mimic epitope of gentamycin and application thereof |
| 04/17/2013 | CN103044526A Antigenic mimic epitope of vardenafil and application thereof |
| 04/17/2013 | CN103044525A Pork flavor peptide as well as production method and application thereof |
| 04/17/2013 | CN103044524A Preparation method of new polypeptide, and application of new polypeptide in treatment |
| 04/17/2013 | CN102382171B Polypeptide for inhibiting hepatitis C virus infected cell and application thereof |
| 04/17/2013 | CN102250219B Method for preparing colistine sulfate B |
| 04/17/2013 | CN102229648B HLA-A*0201 restrictive CTL (cytotoxic T lymphocyte) epitope for tumor antigen Pokemon and application thereof |
| 04/17/2013 | CN101906141B Conjugates of one class of peptide chain and double fatty alcohol chains as well as preparation method and application thereof |
| 04/17/2013 | CN101709078B Immune-modulating peptide |
| 04/16/2013 | US8420778 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 04/16/2013 | US8420777 Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins |
| 04/16/2013 | US8420775 Polypeptides and methods for modulating D1-D2 dopamine receptor interaction and function |
| 04/16/2013 | US8420095 Antigen-containing microspheres for the treatment of allergies |
| 04/16/2013 | CA2498614C Analyzing nerve cell damage |
| 04/11/2013 | WO2013050590A1 Spra1 antimicrobial peptides and uses thereof |
| 04/11/2013 | WO2013050346A1 Template -fixed peptidomimetics as inhibitors of fpr1 |
| 04/11/2013 | US20130090284 Isolation, identification, and uses of antifungal compounds |
| 04/11/2013 | US20130089542 Anti c-met antibody and uses thereof |
| 04/11/2013 | US20130089498 Compositions and methods related to profiling a plurality of cells based on peptide binding |
| 04/11/2013 | CA2850668A1 Srm/mrm assay for the ephrin type-a receptor 2 protein |
| 04/11/2013 | CA2848584A1 Template-fixed peptidomimetics as inhibitors of fpr1 |
| 04/10/2013 | EP2578681A1 Iga-binding peptide and iga purification using same |
| 04/10/2013 | EP2578597A1 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same |
| 04/10/2013 | EP2577537A1 Method for preparing peptide inhibitors of a lipid-activated enzyme and peptides produced by same |
| 04/10/2013 | EP2576638A2 Polymer-conjugated metap2 inhibitors, and therapeutic methods of use thereof |
| 04/10/2013 | EP2576614A2 Class i mhc phosphopeptides for cancer immunotherapy and diagnosis |
| 04/10/2013 | EP2576598A1 Nociceptin mimetics |
| 04/10/2013 | EP2576597A1 Rhamm binding peptides |
| 04/10/2013 | EP2576596A1 Peptide for use as a medicament, in particular for the treatment of cancer |
| 04/10/2013 | EP2576595A1 Mitochondrial penetrating peptides as carriers for anticancer compounds |
| 04/10/2013 | EP2576594A1 Mitochondrial penetrating peptides as carriers for antimicrobials |
| 04/10/2013 | EP2576593A1 Methods for the synthesis of dicarba bridges in peptides |
| 04/10/2013 | EP2575909A1 Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof |
| 04/10/2013 | EP2575874A1 Lactadherin-derived peptides as antiviral agents |
| 04/10/2013 | EP2575855A2 Methods for treating or preventing vascular graft failure |
| 04/10/2013 | CN103038248A RHAMM binding peptides |
| 04/10/2013 | CN103037897A Lactadherin-derived peptides as antiviral agents |
| 04/10/2013 | CN103030683A Peptaibol and preparation method and use thereof |
| 04/10/2013 | CN103030682A Enzyme-sensitive supramolecular hydrogel nano material, gelator and preparation method of gelator |
| 04/10/2013 | CN102321157B Hexapeptide with antioxidant activity and separation method as well as application thereof |
| 04/10/2013 | CN102153628B Alpha1-antitrypsin polyclonal antibody and application of alpha1-antitrypsin polyclonal antibody and polypeptide for alpha1-antitrypsin polyclonal antibody |
| 04/10/2013 | CN101711280B TEM8 peptides and vaccines comprising the same |
| 04/09/2013 | US8415305 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 04/09/2013 | US8415300 Sustained release of microcrystalline peptide suspensions |
| 04/09/2013 | US8415296 Oxyntomodulin peptide analogue |
| 04/09/2013 | US8415294 Cyclodepsipeptides with antineoplastic activity and methods of using to inhibit cancer and microbial growth |
| 04/09/2013 | CA2536436C 2-amido-4-aryloxy-1-carbonyl pyrrolidine derivatives as inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 04/09/2013 | CA2361658C T helper cell epitopes |
| 04/04/2013 | WO2013048956A2 Solid phase extraction separation method |
| 04/04/2013 | WO2013047128A1 Peptide and angiotensin-converting enzyme inhibitor |
| 04/04/2013 | WO2013045854A1 Fluorogenic peptidase substrate |